NVCR Q1 2017 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$35M+167.2% YoY

Gross Profit

$23M66.6% margin

Operating Income

-$13M-38.3% margin

Net Income

-$18M-51.7% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+15.3%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$29M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$265M

Total Liabilities

$136M

Stockholders' Equity

$129M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$13M	+167.2%
Gross Profit	$23M	$5M	+357.8%
Operating Income	-$13M	-$32M	+58.1%
Net Income	-$18M	-$35M	+49.1%

Geographic Segments

UNITED STATES

$29M84%

E M E A

$6M16%

JAPAN

$53,0000%